The past week saw the All Ords [XAO] crack the 6,000-point mark, only briefly, but it still made it through. Last week saw many companies on the market moving up in line with the broader move of the All Ords. Financials had a strong week, posting gains of 11.13%…
World Markets: Global Insights into Financial Trends and Investment Opportunities
When concerned with the global economy, it’s important to look beyond the powerhouses that are often in the spotlight, and to look at the various emerging markets operating just off stage.
Today’s biggest emerging markets (BEMs), include Argentina, Brazil, China, India, Indonesia, Mexico, Poland, South Africa, South Korea and Turkey. Not as big, but still making impact, are Egypt, Iran, Nigeria, Pakistan, Russia, Saudi Arabia, Taiwan, and Thailand.
The Race Is On to Find a COVID-19 Vaccine — How Close Are We?
There are 12 companies in the race to find a vaccine for COVID-19. And global stock markets are already bouncing back hard on the back of news that a solution is close. There’s no doubt it’ll be a great moment for humanity when we get this cure. From an investing point of view, the rewards […]
The Race Is On to Find a COVID-19 Vaccine — How Close Are We?
There are 12 companies in the race to find a vaccine for COVID-19. And global stock markets are already bouncing back hard on the back of news that a solution is close. There’s no doubt it’ll be a great moment for humanity when we get this cure…
This Opportunity Is More than Just Drugs
When it comes to biotechs, it’s easy to get hung up on drugs. After all, drugs are the centrepiece of healthcare. They are the medicine that cures what ails us. Or at least, that’s the intention. However, as we all know, drugs come in many different shapes and forms. An overlooked but equally important part […]
Deferring Doom Doesn’t Work
Governments and central banks around the world are busy forestalling. The question is whether it’s the inevitable. Job losses, bankruptcies, mortgage defaults, corporate bond defaults, austerity or sovereign debt defaults, and plenty more. Does delaying them lead to avoiding them in the end? I’m not so sure, either way. But we’re going to find out […]
This Biotech Investment Opportunity Is More than Just Drugs
When it comes to biotech, it’s easy to get hung up on drugs.Ryan Dinse has spent the last three days covering Synthetic Biology. Or as he likes to call it, ‘synbio’. This is a story that you won’t find anywhere else, and an investment opportunity that can’t be ignored…





